Gene Symbol | Gene ID | Gene Info |
---|---|---|
En1
|
ENSMUSG00000058665.7 | engrailed 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_120607077_120607228 | En1 | 4734 | 0.241603 | -0.83 | 4.4e-15 | Click! |
chr1_120602824_120602975 | En1 | 481 | 0.834702 | -0.79 | 1.1e-12 | Click! |
chr1_120586588_120586762 | En1 | 15743 | 0.208207 | -0.76 | 1.5e-11 | Click! |
chr1_120603329_120603633 | En1 | 1063 | 0.569189 | -0.73 | 3.4e-10 | Click! |
chr1_120603018_120603226 | En1 | 704 | 0.723040 | -0.71 | 1.2e-09 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_103826611_103826778 | 15.93 |
Hbb-bs |
hemoglobin, beta adult s chain |
1031 |
0.23 |
chr9_48340771_48341057 | 11.65 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
16 |
0.98 |
chr16_11423409_11423900 | 10.81 |
Snx29 |
sorting nexin 29 |
2946 |
0.31 |
chr7_103870533_103870999 | 9.81 |
Olfr66 |
olfactory receptor 66 |
11475 |
0.06 |
chr11_48855844_48857180 | 9.67 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chr2_62619174_62619348 | 9.59 |
Ifih1 |
interferon induced with helicase C domain 1 |
20212 |
0.17 |
chr9_124257362_124257899 | 9.52 |
Gm39469 |
predicted gene, 39469 |
24509 |
0.16 |
chrX_170005299_170005846 | 8.04 |
Erdr1 |
erythroid differentiation regulator 1 |
4087 |
0.19 |
chr5_96919251_96919574 | 7.99 |
Gm8013 |
predicted gene 8013 |
1860 |
0.18 |
chr11_75450317_75450540 | 7.83 |
Wdr81 |
WD repeat domain 81 |
648 |
0.47 |
chr12_24633832_24634168 | 7.79 |
Gm6969 |
predicted pseudogene 6969 |
5010 |
0.17 |
chrX_142680720_142682167 | 7.78 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr3_100483327_100483488 | 7.78 |
Tent5c |
terminal nucleotidyltransferase 5C |
5787 |
0.15 |
chr11_44508501_44508818 | 7.55 |
Rnf145 |
ring finger protein 145 |
10305 |
0.16 |
chr2_84842012_84842290 | 7.51 |
Slc43a1 |
solute carrier family 43, member 1 |
1526 |
0.26 |
chr17_40812191_40812348 | 7.48 |
Rhag |
Rhesus blood group-associated A glycoprotein |
1085 |
0.44 |
chr15_80532243_80532574 | 7.42 |
Enthd1 |
ENTH domain containing 1 |
28062 |
0.13 |
chr6_148517623_148517896 | 7.32 |
Tmtc1 |
transmembrane and tetratricopeptide repeat containing 1 |
73370 |
0.08 |
chr6_116286832_116287192 | 7.25 |
Zfand4 |
zinc finger, AN1-type domain 4 |
459 |
0.75 |
chr3_100482353_100482683 | 7.21 |
Tent5c |
terminal nucleotidyltransferase 5C |
6676 |
0.15 |
chr3_103171228_103172264 | 7.16 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr11_117838543_117838973 | 7.13 |
Afmid |
arylformamidase |
6485 |
0.09 |
chr14_70712651_70712802 | 7.10 |
Xpo7 |
exportin 7 |
4691 |
0.18 |
chr7_127091121_127091448 | 7.10 |
AI467606 |
expressed sequence AI467606 |
75 |
0.92 |
chr9_103288259_103288431 | 7.09 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
48 |
0.97 |
chr1_82373706_82374341 | 7.06 |
Gm19552 |
predicted gene, 19552 |
21806 |
0.14 |
chr9_44580129_44580422 | 6.99 |
Gm47230 |
predicted gene, 47230 |
648 |
0.47 |
chr6_120957140_120957456 | 6.91 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
425 |
0.72 |
chr10_127508848_127510720 | 6.89 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr15_103255651_103255895 | 6.70 |
Nfe2 |
nuclear factor, erythroid derived 2 |
334 |
0.79 |
chr11_116616197_116616677 | 6.69 |
Rhbdf2 |
rhomboid 5 homolog 2 |
7763 |
0.1 |
chr16_49771611_49771888 | 6.63 |
Gm15518 |
predicted gene 15518 |
27121 |
0.19 |
chr10_115817661_115817814 | 6.61 |
Tspan8 |
tetraspanin 8 |
453 |
0.88 |
chr1_181335118_181335287 | 6.47 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
17426 |
0.15 |
chr4_130715186_130715488 | 6.46 |
Snord85 |
small nucleolar RNA, C/D box 85 |
34297 |
0.11 |
chr5_143639756_143640070 | 6.35 |
Cyth3 |
cytohesin 3 |
3562 |
0.24 |
chrX_9256889_9257156 | 6.33 |
Gm14862 |
predicted gene 14862 |
123 |
0.95 |
chr5_50128978_50129261 | 6.29 |
4930448I18Rik |
RIKEN cDNA 4930448I18 gene |
22214 |
0.2 |
chr11_87756139_87756345 | 6.28 |
Mir142 |
microRNA 142 |
622 |
0.29 |
chr7_24371478_24371804 | 6.16 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
1303 |
0.24 |
chr11_98766610_98767640 | 6.16 |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
3301 |
0.13 |
chr1_139276711_139276881 | 5.97 |
Crb1 |
crumbs family member 1, photoreceptor morphogenesis associated |
21034 |
0.2 |
chr5_134913846_134914156 | 5.92 |
Cldn13 |
claudin 13 |
1525 |
0.2 |
chr13_36087073_36087280 | 5.89 |
Fars2 |
phenylalanine-tRNA synthetase 2 (mitochondrial) |
30236 |
0.14 |
chr3_51230204_51230396 | 5.89 |
Gm38357 |
predicted gene, 38357 |
1617 |
0.3 |
chr2_79259353_79259890 | 5.87 |
Itga4 |
integrin alpha 4 |
3674 |
0.29 |
chr1_82824949_82825124 | 5.85 |
Gm17764 |
predicted gene, 17764 |
2175 |
0.16 |
chr2_167043032_167043339 | 5.84 |
Znfx1 |
zinc finger, NFX1-type containing 1 |
310 |
0.79 |
chr13_119601169_119601466 | 5.84 |
Tmem267 |
transmembrane protein 267 |
5333 |
0.15 |
chr9_109094576_109096217 | 5.82 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr4_134865487_134865649 | 5.78 |
Rhd |
Rh blood group, D antigen |
1032 |
0.5 |
chr10_40124756_40124956 | 5.71 |
Gm25613 |
predicted gene, 25613 |
15394 |
0.13 |
chr10_75697073_75697253 | 5.69 |
Cabin1 |
calcineurin binding protein 1 |
3212 |
0.18 |
chr5_143655651_143655837 | 5.65 |
Cyth3 |
cytohesin 3 |
4503 |
0.22 |
chr6_67161663_67162061 | 5.65 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr4_109255748_109256041 | 5.63 |
Calr4 |
calreticulin 4 |
11312 |
0.19 |
chr5_143700384_143700543 | 5.59 |
Usp42 |
ubiquitin specific peptidase 42 |
15150 |
0.17 |
chr3_66563505_66563681 | 5.57 |
Gm17952 |
predicted gene, 17952 |
42 |
0.99 |
chr17_17004872_17005579 | 5.56 |
BC002059 |
cDNA sequence BC002059 |
32315 |
0.18 |
chr8_111929784_111929948 | 5.54 |
Tmem231 |
transmembrane protein 231 |
1706 |
0.27 |
chr17_56958124_56958403 | 5.51 |
Gm49887 |
predicted gene, 49887 |
57 |
0.94 |
chr6_121111643_121111794 | 5.49 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
1624 |
0.32 |
chr5_92149707_92149865 | 5.46 |
Gm15710 |
predicted gene 15710 |
8857 |
0.12 |
chr11_102377299_102377450 | 5.41 |
Bloodlinc |
Bloodlinc, erythroid developmental long intergenic non-protein coding transcript |
354 |
0.76 |
chr18_56904223_56904378 | 5.38 |
Gm18087 |
predicted gene, 18087 |
11788 |
0.2 |
chr7_116503804_116504452 | 5.37 |
Nucb2 |
nucleobindin 2 |
241 |
0.9 |
chr9_66988315_66988469 | 5.37 |
Gm24225 |
predicted gene, 24225 |
7207 |
0.16 |
chr19_5663928_5664089 | 5.34 |
Sipa1 |
signal-induced proliferation associated gene 1 |
301 |
0.73 |
chr11_32251299_32251675 | 5.33 |
Nprl3 |
nitrogen permease regulator-like 3 |
1209 |
0.31 |
chr17_50071266_50071512 | 5.33 |
Rftn1 |
raftlin lipid raft linker 1 |
22943 |
0.18 |
chr7_141770985_141771320 | 5.25 |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
17820 |
0.15 |
chr8_83423048_83423368 | 5.24 |
Scoc |
short coiled-coil protein |
14619 |
0.13 |
chr8_123990516_123990684 | 5.22 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
7478 |
0.1 |
chr5_139377313_139377823 | 5.20 |
Gpr146 |
G protein-coupled receptor 146 |
129 |
0.93 |
chr17_71268038_71268559 | 5.20 |
Emilin2 |
elastin microfibril interfacer 2 |
299 |
0.88 |
chr12_72535708_72536908 | 5.19 |
Pcnx4 |
pecanex homolog 4 |
75 |
0.97 |
chr14_118795769_118796127 | 5.17 |
Cldn10 |
claudin 10 |
8030 |
0.16 |
chr3_40744698_40745243 | 5.16 |
Hspa4l |
heat shock protein 4 like |
412 |
0.82 |
chr5_29963573_29963740 | 5.16 |
Gm43386 |
predicted gene 43386 |
12938 |
0.16 |
chr11_15698109_15698281 | 5.16 |
Gm12010 |
predicted gene 12010 |
215889 |
0.02 |
chr5_32950813_32951166 | 5.16 |
Depdc5 |
DEP domain containing 5 |
6876 |
0.16 |
chr8_124019948_124020121 | 5.15 |
Taf5l |
TATA-box binding protein associated factor 5 like |
906 |
0.35 |
chr11_19924323_19926342 | 5.14 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr3_37558200_37558362 | 5.12 |
Gm12564 |
predicted gene 12564 |
1778 |
0.27 |
chr1_165396375_165396531 | 5.12 |
Dcaf6 |
DDB1 and CUL4 associated factor 6 |
7692 |
0.14 |
chr17_71259396_71259741 | 5.08 |
Emilin2 |
elastin microfibril interfacer 2 |
3222 |
0.2 |
chr17_17234637_17235329 | 5.06 |
Gm5165 |
predicted gene 5165 |
111 |
0.97 |
chr1_72255145_72255783 | 5.03 |
Gm25939 |
predicted gene, 25939 |
456 |
0.72 |
chr2_77515708_77515986 | 5.02 |
Zfp385b |
zinc finger protein 385B |
3688 |
0.32 |
chr2_131205772_131206168 | 4.98 |
Ap5s1 |
adaptor-related protein 5 complex, sigma 1 subunit |
1108 |
0.33 |
chr17_83736835_83737028 | 4.98 |
Mta3 |
metastasis associated 3 |
7767 |
0.25 |
chr8_83625807_83625958 | 4.97 |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
17329 |
0.09 |
chr10_61516990_61517141 | 4.97 |
Gm17829 |
predicted gene, 17829 |
6480 |
0.12 |
chr13_112816068_112816355 | 4.93 |
Plpp1 |
phospholipid phosphatase 1 |
15348 |
0.15 |
chr14_67000360_67000524 | 4.90 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
66 |
0.97 |
chr14_21112879_21113034 | 4.90 |
Adk |
adenosine kinase |
36804 |
0.17 |
chr14_25402509_25402704 | 4.89 |
Gm26660 |
predicted gene, 26660 |
22997 |
0.15 |
chr7_103877549_103877803 | 4.87 |
Olfr66 |
olfactory receptor 66 |
4565 |
0.07 |
chr4_129464231_129464446 | 4.81 |
Bsdc1 |
BSD domain containing 1 |
204 |
0.88 |
chr14_36691019_36691329 | 4.77 |
Gm17940 |
predicted gene, 17940 |
71896 |
0.1 |
chr13_20151466_20151636 | 4.77 |
Elmo1 |
engulfment and cell motility 1 |
33656 |
0.22 |
chr3_103130224_103130445 | 4.75 |
Dennd2c |
DENN/MADD domain containing 2C |
2778 |
0.18 |
chr6_52225788_52226610 | 4.74 |
Hoxa9 |
homeobox A9 |
10 |
0.91 |
chr2_121037044_121037214 | 4.73 |
Epb42 |
erythrocyte membrane protein band 4.2 |
57 |
0.95 |
chr2_103957767_103958059 | 4.71 |
Lmo2 |
LIM domain only 2 |
73 |
0.96 |
chr11_86664070_86664249 | 4.70 |
Vmp1 |
vacuole membrane protein 1 |
586 |
0.71 |
chr5_76627755_76627906 | 4.69 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
28682 |
0.14 |
chr18_67670424_67670597 | 4.67 |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
19714 |
0.14 |
chr19_59359289_59359452 | 4.64 |
Pdzd8 |
PDZ domain containing 8 |
13590 |
0.14 |
chr16_73821464_73821632 | 4.64 |
Robo2 |
roundabout guidance receptor 2 |
78337 |
0.11 |
chr13_63564531_63566515 | 4.62 |
Ptch1 |
patched 1 |
212 |
0.91 |
chr11_95777553_95777757 | 4.59 |
Polr2k-ps |
polymerase (RNA) II (DNA directed) polypeptide K, pseudogene |
16164 |
0.12 |
chr10_20905937_20906088 | 4.58 |
Rps2-ps3 |
ribosomal protein S2, pseudogene 3 |
27039 |
0.19 |
chr15_66825863_66826251 | 4.57 |
Sla |
src-like adaptor |
5589 |
0.21 |
chr11_102924509_102924690 | 4.56 |
Kif18b |
kinesin family member 18B |
489 |
0.67 |
chr17_29499759_29499915 | 4.53 |
Pim1 |
proviral integration site 1 |
6430 |
0.11 |
chr13_45545582_45545975 | 4.52 |
Gmpr |
guanosine monophosphate reductase |
375 |
0.91 |
chr2_93008105_93008300 | 4.52 |
Prdm11 |
PR domain containing 11 |
5708 |
0.22 |
chr9_66193900_66194051 | 4.51 |
Dapk2 |
death-associated protein kinase 2 |
26772 |
0.17 |
chr10_62344446_62344629 | 4.51 |
Hk1 |
hexokinase 1 |
1815 |
0.29 |
chr17_36869921_36870137 | 4.50 |
Trim10 |
tripartite motif-containing 10 |
455 |
0.63 |
chr10_61123577_61123747 | 4.49 |
Gm44308 |
predicted gene, 44308 |
1573 |
0.32 |
chr3_100682368_100682522 | 4.48 |
Man1a2 |
mannosidase, alpha, class 1A, member 2 |
2168 |
0.18 |
chr2_156924238_156924504 | 4.48 |
Gm14278 |
predicted gene 14278 |
8988 |
0.1 |
chr7_90146417_90146617 | 4.45 |
Gm45222 |
predicted gene 45222 |
569 |
0.64 |
chr8_84197696_84198961 | 4.44 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr1_165818578_165818826 | 4.43 |
Gm23402 |
predicted gene, 23402 |
8960 |
0.1 |
chr6_52899660_52899845 | 4.42 |
Jazf1 |
JAZF zinc finger 1 |
9868 |
0.23 |
chrX_170004689_170005233 | 4.42 |
Erdr1 |
erythroid differentiation regulator 1 |
4698 |
0.18 |
chr3_127889681_127889845 | 4.39 |
Fam241a |
family with sequence similarity 241, member A |
6525 |
0.13 |
chr5_90477467_90477647 | 4.39 |
Afp |
alpha fetoprotein |
13180 |
0.14 |
chr5_97007576_97007868 | 4.38 |
Bmp2k |
BMP2 inducible kinase |
10033 |
0.14 |
chr11_30997977_30998159 | 4.37 |
Gm12102 |
predicted gene 12102 |
5830 |
0.18 |
chr5_143625871_143626085 | 4.37 |
Cyth3 |
cytohesin 3 |
3444 |
0.24 |
chr13_23581338_23582324 | 4.36 |
H4c4 |
H4 clustered histone 4 |
233 |
0.73 |
chr13_96698181_96698347 | 4.35 |
Gm48575 |
predicted gene, 48575 |
20141 |
0.14 |
chr14_121355790_121356113 | 4.34 |
Stk24 |
serine/threonine kinase 24 |
3917 |
0.25 |
chr17_47535748_47536285 | 4.32 |
Ccnd3 |
cyclin D3 |
30775 |
0.1 |
chr4_46854042_46854371 | 4.30 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
5696 |
0.29 |
chr14_69304490_69304667 | 4.30 |
Synb |
syncytin b |
10279 |
0.09 |
chr9_70926847_70927150 | 4.29 |
Gm32017 |
predicted gene, 32017 |
3490 |
0.25 |
chr10_43598436_43598598 | 4.29 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
5078 |
0.15 |
chr14_69522740_69522920 | 4.29 |
Gm27179 |
predicted gene 27179 |
10281 |
0.1 |
chr17_25947821_25948028 | 4.28 |
Nhlrc4 |
NHL repeat containing 4 |
2963 |
0.09 |
chr3_100425723_100425874 | 4.28 |
4930406D18Rik |
RIKEN cDNA 4930406D18 gene |
607 |
0.68 |
chr18_67436617_67436802 | 4.27 |
Afg3l2 |
AFG3-like AAA ATPase 2 |
761 |
0.59 |
chrX_53088731_53089002 | 4.26 |
Plac1 |
placental specific protein 1 |
25664 |
0.08 |
chr1_181334651_181334972 | 4.25 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
17817 |
0.15 |
chrX_56728633_56728810 | 4.25 |
Fhl1 |
four and a half LIM domains 1 |
3066 |
0.21 |
chr4_115047820_115048056 | 4.23 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
8488 |
0.15 |
chr7_25686729_25687529 | 4.22 |
Tgfb1 |
transforming growth factor, beta 1 |
127 |
0.91 |
chr8_88288608_88288781 | 4.22 |
Adcy7 |
adenylate cyclase 7 |
453 |
0.83 |
chr9_64792798_64792980 | 4.21 |
Dennd4a |
DENN/MADD domain containing 4A |
18451 |
0.18 |
chr1_193664374_193664566 | 4.20 |
Mir205hg |
Mir205 host gene |
154296 |
0.04 |
chr13_3861425_3861583 | 4.20 |
Calm5 |
calmodulin 5 |
7236 |
0.12 |
chr4_132428123_132428546 | 4.19 |
Phactr4 |
phosphatase and actin regulator 4 |
5845 |
0.1 |
chr6_125573659_125573981 | 4.19 |
Vwf |
Von Willebrand factor |
7569 |
0.21 |
chr15_59059112_59059433 | 4.19 |
Mtss1 |
MTSS I-BAR domain containing 1 |
3808 |
0.27 |
chr1_161792328_161792513 | 4.17 |
Fasl |
Fas ligand (TNF superfamily, member 6) |
3925 |
0.17 |
chr2_120660523_120660854 | 4.17 |
Stard9 |
START domain containing 9 |
8272 |
0.15 |
chr14_118750911_118751082 | 4.17 |
Gm27198 |
predicted gene 27198 |
15851 |
0.15 |
chr4_145221682_145222086 | 4.15 |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
24986 |
0.17 |
chr8_69901870_69903353 | 4.15 |
Ndufa13 |
NADH:ubiquinone oxidoreductase subunit A13 |
53 |
0.51 |
chr6_136858196_136858347 | 4.13 |
Art4 |
ADP-ribosyltransferase 4 |
538 |
0.6 |
chr7_141146101_141146426 | 4.13 |
Ptdss2 |
phosphatidylserine synthase 2 |
8360 |
0.08 |
chr10_128525093_128526268 | 4.11 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chrX_136135584_136135889 | 4.11 |
Bex4 |
brain expressed X-linked 4 |
3260 |
0.16 |
chr7_135793057_135793367 | 4.09 |
Gm36431 |
predicted gene, 36431 |
23622 |
0.16 |
chr2_164773568_164773719 | 4.09 |
Ube2c |
ubiquitin-conjugating enzyme E2C |
3740 |
0.08 |
chr5_123193993_123194155 | 4.09 |
Gm43409 |
predicted gene 43409 |
2486 |
0.15 |
chr16_35763893_35764232 | 4.09 |
Slc49a4 |
solute carrier family 49 member 4 |
5268 |
0.15 |
chr3_103176749_103177100 | 4.08 |
Gm27024 |
predicted gene, 27024 |
3519 |
0.16 |
chr3_152114756_152115116 | 4.06 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
6414 |
0.15 |
chr5_140606846_140607467 | 4.06 |
Lfng |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
164 |
0.83 |
chr18_78122702_78122882 | 4.04 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
539 |
0.82 |
chr9_54704347_54704689 | 4.03 |
Mir5710 |
microRNA 5710 |
3795 |
0.15 |
chr7_126042390_126042861 | 4.03 |
Gm44874 |
predicted gene 44874 |
21822 |
0.17 |
chr19_59905716_59906059 | 4.02 |
Gm17203 |
predicted gene 17203 |
4825 |
0.24 |
chr11_115899580_115900578 | 4.01 |
Smim5 |
small integral membrane protein 5 |
99 |
0.93 |
chr14_76532822_76533109 | 4.01 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6349 |
0.21 |
chr7_99594452_99594625 | 4.01 |
Arrb1 |
arrestin, beta 1 |
55 |
0.96 |
chr6_67058429_67058597 | 4.00 |
E230016M11Rik |
RIKEN cDNA E230016M11 gene |
18247 |
0.11 |
chr11_64931735_64931888 | 3.99 |
Elac2 |
elaC ribonuclease Z 2 |
47227 |
0.15 |
chr4_129386618_129386884 | 3.99 |
Gm12980 |
predicted gene 12980 |
6907 |
0.12 |
chr2_22777785_22778079 | 3.98 |
Apbb1ip |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
3487 |
0.19 |
chr4_154023722_154024341 | 3.98 |
Smim1 |
small integral membrane protein 1 |
292 |
0.82 |
chr13_107577239_107577601 | 3.98 |
Gm32004 |
predicted gene, 32004 |
12089 |
0.22 |
chr13_119598970_119599326 | 3.97 |
Tmem267 |
transmembrane protein 267 |
7502 |
0.14 |
chr17_83684505_83684810 | 3.97 |
Mta3 |
metastasis associated 3 |
21506 |
0.21 |
chr11_100737141_100737346 | 3.96 |
Rab5c |
RAB5C, member RAS oncogene family |
933 |
0.37 |
chr13_92847494_92847645 | 3.96 |
Mtx3 |
metaxin 3 |
2371 |
0.33 |
chr9_57757716_57757904 | 3.95 |
Clk3 |
CDC-like kinase 3 |
2489 |
0.21 |
chr9_35122875_35123056 | 3.94 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
3697 |
0.16 |
chr3_100533489_100533786 | 3.93 |
Gm42868 |
predicted gene 42868 |
36208 |
0.11 |
chr19_17355480_17355635 | 3.93 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
1110 |
0.57 |
chr5_129977865_129978035 | 3.92 |
Vkorc1l1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
956 |
0.4 |
chr6_83395648_83395823 | 3.92 |
Mir6374 |
microRNA 6374 |
5367 |
0.13 |
chr10_41006809_41006996 | 3.91 |
Gm48057 |
predicted gene, 48057 |
28293 |
0.15 |
chr14_21848829_21849211 | 3.91 |
Comtd1 |
catechol-O-methyltransferase domain containing 1 |
43 |
0.9 |
chr2_153227994_153228293 | 3.90 |
Tspyl3 |
TSPY-like 3 |
2702 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.5 | 7.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.5 | 12.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
2.5 | 7.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.4 | 14.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.2 | 8.8 | GO:0008228 | opsonization(GO:0008228) |
2.2 | 6.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.1 | 6.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.9 | 5.7 | GO:0032782 | bile acid secretion(GO:0032782) |
1.9 | 9.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.8 | 1.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
1.8 | 5.3 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
1.7 | 5.2 | GO:0050904 | diapedesis(GO:0050904) |
1.7 | 10.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.7 | 3.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.7 | 5.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.7 | 1.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.7 | 5.0 | GO:0036394 | amylase secretion(GO:0036394) |
1.6 | 3.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.6 | 7.8 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.6 | 1.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.5 | 4.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.5 | 3.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.5 | 6.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.5 | 2.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.4 | 4.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.4 | 8.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.4 | 2.8 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
1.4 | 4.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.4 | 7.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.4 | 8.3 | GO:0015671 | oxygen transport(GO:0015671) |
1.4 | 5.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.4 | 6.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.4 | 8.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.4 | 6.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.4 | 5.5 | GO:0032264 | IMP salvage(GO:0032264) |
1.4 | 5.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.3 | 4.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.3 | 4.0 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.3 | 4.0 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.3 | 2.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.3 | 3.8 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.3 | 3.8 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.2 | 4.9 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.2 | 4.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.2 | 6.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.2 | 1.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.2 | 1.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.2 | 4.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.2 | 29.0 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.1 | 2.3 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.1 | 3.4 | GO:0070627 | ferrous iron import(GO:0070627) |
1.1 | 2.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.1 | 2.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.1 | 2.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.1 | 3.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.1 | 4.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.1 | 3.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.1 | 4.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.1 | 3.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.1 | 2.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.1 | 3.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.1 | 2.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.1 | 3.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.1 | 4.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.1 | 1.1 | GO:0046782 | regulation of viral transcription(GO:0046782) |
1.1 | 2.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.1 | 3.2 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.1 | 11.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.0 | 1.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.0 | 17.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.0 | 3.1 | GO:0002894 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
1.0 | 3.1 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
1.0 | 3.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.0 | 3.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.0 | 4.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.0 | 3.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.0 | 3.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.0 | 3.0 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.0 | 4.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.0 | 3.0 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.0 | 6.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.0 | 3.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.0 | 3.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.0 | 3.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.0 | 7.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.0 | 7.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.0 | 2.9 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
1.0 | 2.9 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.0 | 3.8 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.0 | 3.8 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.9 | 2.8 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.9 | 4.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.9 | 2.8 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.9 | 2.8 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.9 | 6.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.9 | 4.6 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.9 | 3.7 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.9 | 2.7 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.9 | 1.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.9 | 1.8 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.9 | 4.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.9 | 2.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.9 | 2.7 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.9 | 3.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.9 | 2.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.9 | 4.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.9 | 2.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.9 | 2.6 | GO:0000087 | mitotic M phase(GO:0000087) |
0.9 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.9 | 0.9 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.9 | 9.5 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.9 | 2.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.9 | 2.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.9 | 1.7 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.9 | 3.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.9 | 7.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 2.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.8 | 5.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.8 | 2.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.8 | 2.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.8 | 0.8 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.8 | 1.7 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.8 | 15.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 7.5 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.8 | 0.8 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.8 | 5.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.8 | 4.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.8 | 2.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.8 | 3.2 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.8 | 1.6 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.8 | 1.6 | GO:0001555 | oocyte growth(GO:0001555) |
0.8 | 2.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.8 | 2.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 2.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.8 | 2.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.8 | 6.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.8 | 1.6 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.8 | 18.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.8 | 2.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.8 | 2.3 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.8 | 1.5 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.8 | 2.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.8 | 2.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.8 | 1.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.8 | 3.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 0.8 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.8 | 0.8 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.8 | 0.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.8 | 2.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.8 | 2.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.7 | 3.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 12.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.7 | 0.7 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 1.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.7 | 0.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.7 | 2.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.7 | 2.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.7 | 2.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 2.9 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.7 | 2.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.7 | 9.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.7 | 1.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.7 | 1.4 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.7 | 3.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.7 | 3.6 | GO:0018904 | ether metabolic process(GO:0018904) |
0.7 | 2.9 | GO:0015705 | iodide transport(GO:0015705) |
0.7 | 1.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.7 | 4.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 2.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.7 | 2.8 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.7 | 3.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.7 | 2.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.7 | 14.5 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.7 | 0.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.7 | 3.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.7 | 1.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.7 | 2.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.7 | 1.4 | GO:1901563 | response to camptothecin(GO:1901563) |
0.7 | 2.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.7 | 1.4 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.7 | 2.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.7 | 0.7 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.7 | 4.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.7 | 2.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.7 | 8.1 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.7 | 0.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.7 | 1.3 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.7 | 2.0 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.7 | 2.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.7 | 0.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.7 | 1.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.7 | 0.7 | GO:0061010 | gall bladder development(GO:0061010) |
0.7 | 2.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.7 | 7.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.7 | 9.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.7 | 3.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.7 | 4.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.7 | 0.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.7 | 2.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.6 | 4.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.6 | 1.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 3.2 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.6 | 7.7 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.6 | 3.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.6 | 1.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.6 | 0.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.6 | 1.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 0.6 | GO:0009838 | abscission(GO:0009838) |
0.6 | 0.6 | GO:0046618 | xenobiotic transport(GO:0042908) drug export(GO:0046618) |
0.6 | 1.9 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.6 | 1.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 1.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.6 | 2.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.6 | 1.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.6 | 1.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.6 | 7.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.6 | 1.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.6 | 4.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.6 | 1.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.6 | 1.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 0.6 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.6 | 3.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 2.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.6 | 2.4 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.6 | 9.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.6 | 0.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.6 | 1.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.6 | 1.2 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.6 | 3.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.6 | 1.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 5.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.6 | 2.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.6 | 1.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.6 | 2.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.6 | 2.9 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.6 | 1.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.6 | 1.7 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.6 | 1.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.6 | 0.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.6 | 6.9 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.6 | 1.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 4.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.6 | 8.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.6 | 1.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.6 | 0.6 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.6 | 0.6 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.6 | 2.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.6 | 5.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 1.7 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.6 | 4.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 1.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.6 | 2.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 1.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.6 | 3.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 3.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.6 | 3.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.6 | 0.6 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.6 | 2.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.6 | 0.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 2.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 2.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.5 | 1.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 1.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.5 | 4.4 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.5 | 0.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 3.8 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.5 | 5.4 | GO:0010965 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.5 | 1.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.5 | 2.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.5 | 4.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.5 | 1.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.5 | 3.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.5 | 2.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.5 | 3.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.5 | 0.5 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.5 | 0.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.5 | 1.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.5 | 1.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 3.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.5 | 0.5 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.5 | 4.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.5 | 1.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 1.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.5 | 2.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.5 | 1.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 3.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 2.6 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.5 | 5.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.5 | 0.5 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.5 | 1.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.5 | 1.6 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.5 | 0.5 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.5 | 2.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 2.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 0.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.5 | 0.5 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.5 | 4.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.5 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 2.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 1.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.5 | 1.0 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.5 | 1.5 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.5 | 2.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.5 | 5.5 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.5 | 0.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.5 | 2.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.5 | 2.0 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.5 | 0.5 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.5 | 1.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 1.0 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.5 | 2.5 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.5 | 4.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 0.5 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.5 | 2.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.5 | 7.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.5 | 1.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 1.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.5 | 3.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.5 | 2.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 2.9 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.5 | 1.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.5 | 1.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 2.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.5 | 1.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.5 | 1.0 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.5 | 11.0 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.5 | 5.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.5 | 0.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.5 | 0.9 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 1.9 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.5 | 1.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 0.9 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.5 | 1.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.5 | 1.4 | GO:0080009 | mRNA methylation(GO:0080009) |
0.5 | 0.5 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.5 | 2.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.5 | 1.4 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 2.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.5 | 1.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.5 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.5 | 1.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 1.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 1.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 0.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.5 | 1.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.5 | 2.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 3.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.5 | 0.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.5 | 2.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.5 | 0.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 2.3 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.5 | 0.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 1.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.5 | 1.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 2.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 2.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.4 | 0.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 0.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 1.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.4 | 0.9 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 2.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 0.4 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.4 | 0.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 1.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 1.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 2.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.4 | 1.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 0.9 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.4 | 8.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 3.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 1.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 0.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 1.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.4 | 2.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 2.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 3.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.4 | 1.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.4 | 2.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.4 | 1.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 2.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 2.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 1.7 | GO:0015879 | carnitine transport(GO:0015879) |
0.4 | 9.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.4 | 2.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 14.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.4 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.4 | 0.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 3.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 1.3 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 3.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 1.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 1.3 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.4 | 1.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 2.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 2.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.4 | 6.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 8.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 5.5 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.4 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 1.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 0.4 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 8.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 2.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 1.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.4 | 2.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 0.8 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 1.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 0.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 1.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 2.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 4.5 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.4 | 1.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 0.8 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.4 | 1.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 2.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 0.4 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.4 | 2.4 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.4 | 1.2 | GO:2000002 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.4 | 2.0 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 0.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.4 | 1.6 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.4 | 3.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 1.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.4 | 0.8 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.4 | 3.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 1.2 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.4 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 1.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.4 | 4.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 2.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 1.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 1.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.4 | 1.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.4 | 0.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 0.4 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.4 | 2.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 1.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 2.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 1.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.4 | 1.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.4 | 2.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 1.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 1.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 1.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 1.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 4.2 | GO:0050779 | RNA destabilization(GO:0050779) |
0.4 | 1.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 6.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.4 | 1.5 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.4 | 1.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 0.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.4 | 0.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 4.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.4 | 1.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 2.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.4 | 0.4 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.4 | 2.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 1.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 0.7 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.4 | 1.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 1.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 2.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.4 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.4 | 3.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 1.5 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.4 | 0.7 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.4 | 3.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 6.6 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.4 | 0.4 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) |
0.4 | 1.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.4 | 6.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 3.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 0.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.4 | 0.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.4 | 1.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.4 | 1.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.4 | 1.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.4 | 0.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.4 | 0.4 | GO:0010165 | response to X-ray(GO:0010165) |
0.4 | 1.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.4 | 1.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.4 | 0.7 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 1.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 0.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 0.4 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.4 | 2.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.4 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 1.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 1.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.4 | 4.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.4 | 2.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 2.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 9.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 0.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 2.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.4 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.3 | 1.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.3 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 1.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.3 | 1.4 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.3 | 1.4 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.3 | 1.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 0.7 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 2.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 0.3 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.3 | 0.3 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 1.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 11.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 0.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 2.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 1.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 1.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 8.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 0.3 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.3 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.0 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.3 | 1.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 4.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 2.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.3 | 1.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 1.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.3 | 2.9 | GO:0006414 | translational elongation(GO:0006414) |
0.3 | 0.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 3.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 3.9 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 1.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 2.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 0.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 0.7 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.3 | 0.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 1.3 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.3 | 5.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 1.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 1.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 1.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.3 | 0.6 | GO:0046487 | glyoxylate catabolic process(GO:0009436) glyoxylate metabolic process(GO:0046487) |
0.3 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 0.6 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 0.6 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 1.6 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 0.6 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.3 | 1.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.3 | 1.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.3 | 1.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 3.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 1.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 1.6 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.3 | 5.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 0.3 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.3 | 2.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 4.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.3 | 2.8 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 11.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.3 | 0.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.3 | 2.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 8.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 1.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.3 | 0.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 0.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 0.9 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 2.5 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 6.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 2.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.2 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 1.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 1.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.6 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.3 | 0.3 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.3 | 0.6 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.3 | 0.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.3 | 1.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 0.6 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 1.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 0.6 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.3 | 1.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 0.6 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 1.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 0.3 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.3 | 1.5 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.3 | 0.9 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 0.3 | GO:0032392 | DNA geometric change(GO:0032392) |
0.3 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 0.9 | GO:0071941 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
0.3 | 8.1 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.3 | 0.6 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 0.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.3 | 2.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 0.6 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 0.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 1.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 0.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 0.6 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 2.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.3 | 1.5 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.3 | 2.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 0.6 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 2.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 0.6 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.6 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.3 | 0.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 1.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.3 | 1.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.3 | 2.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 2.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 0.9 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.3 | 0.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.3 | 0.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 0.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 1.7 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.3 | 2.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 0.6 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 1.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 2.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 1.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 3.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.3 | 0.3 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.3 | 1.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 0.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 0.3 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.3 | 1.1 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.3 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.6 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 2.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 0.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 0.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 3.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 0.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 0.6 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.3 | 2.8 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 1.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 5.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 0.6 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 2.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.3 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.3 | 1.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 0.3 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.3 | 1.9 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 0.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.3 | 0.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.3 | 4.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 0.5 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.3 | 0.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.5 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.3 | 0.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 1.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 4.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 0.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 0.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 0.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 1.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 0.3 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 0.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 0.8 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.3 | 0.5 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.3 | 0.5 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 1.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.3 | 0.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 2.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 0.5 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 0.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.3 | 0.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 1.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 0.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 0.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 6.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 10.6 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.3 | 0.3 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.3 | 0.8 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.3 | 9.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.3 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.3 | 0.3 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.3 | 3.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.3 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 0.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 0.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 1.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.3 | 0.8 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.3 | 0.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 2.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 1.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 0.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 1.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.3 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 1.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.2 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.2 | 0.5 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.2 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.7 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.2 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 3.2 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 0.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.2 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 0.2 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.2 | 1.7 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.2 | 2.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.7 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.2 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.2 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 1.7 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.7 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.2 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 1.7 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.7 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 1.9 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 2.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.7 | GO:0042168 | heme metabolic process(GO:0042168) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 1.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 1.4 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.2 | 4.1 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.2 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.2 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.2 | 2.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 1.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.2 | 4.0 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.2 | 1.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 3.8 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 0.2 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.7 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 2.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 1.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 0.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 3.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.7 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.2 | 2.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.2 | GO:0009310 | amine catabolic process(GO:0009310) |
0.2 | 0.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 0.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.2 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 7.9 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.2 | 0.7 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.2 | 0.2 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 2.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.7 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.2 | 4.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 1.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.4 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.7 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.4 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.7 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.2 | 0.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 0.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 0.7 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.2 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 2.6 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 7.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.4 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 1.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 0.4 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 2.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 1.5 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.4 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 0.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 1.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 1.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 0.6 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 2.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 1.9 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 1.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 1.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.2 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 3.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.2 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.2 | 1.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 1.0 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 0.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.8 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.2 | 0.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 0.2 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.4 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 0.4 | GO:0048308 | organelle inheritance(GO:0048308) |
0.2 | 0.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.2 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 1.0 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.2 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 5.6 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 3.1 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.4 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.2 | 5.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 1.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 2.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 1.7 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 0.4 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.2 | 2.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 1.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.2 | 1.3 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.2 | 0.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 1.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 2.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.8 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 0.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.2 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 0.6 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 2.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 0.4 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.2 | 2.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 0.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.2 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 1.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 6.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 2.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.2 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 4.4 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 0.4 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.2 | 2.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.5 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.5 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 0.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 5.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 1.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 3.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 2.7 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.2 | 1.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.2 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 1.1 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.7 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 0.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.2 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 0.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.7 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 2.8 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.2 | 0.5 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 0.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 33.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 1.4 | GO:0044743 | intracellular protein transmembrane import(GO:0044743) |
0.2 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 2.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 0.3 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.2 | 0.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.8 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.2 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 0.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 0.3 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.2 | 1.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 1.5 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.2 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.5 | GO:0070266 | necroptotic process(GO:0070266) |
0.2 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 4.1 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.3 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.2 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.2 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.2 | 1.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 1.8 | GO:0098534 | centriole assembly(GO:0098534) |
0.2 | 3.4 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 0.5 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.2 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 1.9 | GO:0071353 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.2 | 1.8 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.2 | 0.8 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.2 | 0.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.2 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.3 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.2 | 2.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 2.7 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.2 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 1.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.9 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 0.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.2 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.2 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.2 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 2.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.6 | GO:0090151 | outer mitochondrial membrane organization(GO:0007008) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.2 | 0.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 0.6 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 4.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.2 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.3 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.2 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 1.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.8 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 0.6 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 5.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 1.3 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 2.4 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.3 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.1 | 0.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.3 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 3.4 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.7 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.9 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.6 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 1.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.0 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 1.2 | GO:0000819 | sister chromatid segregation(GO:0000819) |
0.1 | 2.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 1.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.3 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 1.0 | GO:0032438 | melanosome organization(GO:0032438) |
0.1 | 0.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.4 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.4 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 4.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.1 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
0.1 | 6.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.5 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 4.1 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.4 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 1.3 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.1 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.3 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 2.4 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.4 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 1.1 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.1 | 0.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.1 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.1 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.8 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.1 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.4 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.1 | 0.5 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.6 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.4 | GO:0034397 | telomere localization(GO:0034397) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 4.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 1.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 1.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 1.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.7 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.5 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 1.5 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.3 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 1.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.2 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) sinoatrial node cell development(GO:0060931) |
0.1 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.1 | 4.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.8 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.1 | GO:1901491 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.2 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.1 | 0.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.8 | GO:1903670 | regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 4.2 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 3.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.1 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.1 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.1 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.1 | 0.2 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.1 | 0.5 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.9 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.5 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.1 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.2 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.7 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 1.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.9 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.3 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.2 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 1.2 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.1 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.7 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 7.4 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.1 | 0.1 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.2 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 1.0 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 6.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 2.5 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 1.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 1.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.6 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.3 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 1.6 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 2.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.6 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.3 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.4 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.9 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 1.7 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.5 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.2 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.5 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.2 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.1 | 1.4 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.4 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.5 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.2 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 1.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 1.4 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.2 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.1 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.1 | 0.1 | GO:0000279 | M phase(GO:0000279) meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.6 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 2.2 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 1.9 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 2.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.2 | GO:0045924 | regulation of female receptivity(GO:0045924) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 1.0 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.1 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 1.1 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 0.6 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.6 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.1 | 0.1 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.1 | 0.4 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.4 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.2 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 6.1 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.2 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 1.6 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.1 | 0.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.1 | 0.8 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 1.0 | GO:0031497 | chromatin assembly(GO:0031497) |
0.1 | 0.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.2 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 1.9 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.1 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.1 | 0.8 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.9 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0008334 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) histone mRNA metabolic process(GO:0008334) |
0.1 | 1.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 1.0 | GO:0003281 | ventricular septum development(GO:0003281) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.3 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.2 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.2 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.9 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.0 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.0 | 0.1 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.0 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.1 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.0 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.0 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.6 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.0 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.3 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.2 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.0 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.1 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.0 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.0 | 0.1 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.0 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.3 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0002759 | positive regulation of antimicrobial peptide production(GO:0002225) regulation of antimicrobial humoral response(GO:0002759) positive regulation of antimicrobial humoral response(GO:0002760) antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.0 | GO:0002524 | hypersensitivity(GO:0002524) |
0.0 | 0.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.1 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.4 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.0 | GO:0046164 | alcohol catabolic process(GO:0046164) |
0.0 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.2 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.0 | 0.0 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 1.1 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.5 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.0 | GO:0002637 | regulation of immunoglobulin production(GO:0002637) |
0.0 | 0.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.3 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.4 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.1 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.0 | 0.1 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.0 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.0 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.0 | 0.0 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.0 | 0.0 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.0 | 0.0 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 16.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.0 | 0.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.2 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 25.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.8 | 5.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.8 | 3.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.8 | 9.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.5 | 4.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.4 | 6.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.3 | 4.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.3 | 3.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.3 | 3.9 | GO:0097413 | Lewy body(GO:0097413) |
1.2 | 3.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.2 | 4.8 | GO:1990130 | Iml1 complex(GO:1990130) |
1.1 | 3.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.1 | 1.1 | GO:1990745 | EARP complex(GO:1990745) |
1.1 | 2.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.1 | 4.2 | GO:0033269 | internode region of axon(GO:0033269) |
1.0 | 5.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.0 | 1.0 | GO:1990423 | RZZ complex(GO:1990423) |
1.0 | 3.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.0 | 3.9 | GO:0072487 | MSL complex(GO:0072487) |
0.9 | 2.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 5.6 | GO:0005818 | aster(GO:0005818) |
0.9 | 3.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.9 | 3.7 | GO:0000938 | GARP complex(GO:0000938) |
0.9 | 3.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.9 | 2.6 | GO:0055087 | Ski complex(GO:0055087) |
0.9 | 1.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.9 | 2.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.8 | 2.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.8 | 4.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.8 | 3.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 12.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.8 | 4.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 3.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 2.4 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.8 | 0.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.8 | 7.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.8 | 2.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.8 | 0.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.8 | 6.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 10.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.7 | 2.2 | GO:1990462 | omegasome(GO:1990462) |
0.7 | 7.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.7 | 7.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 2.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 1.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.7 | 2.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.7 | 2.1 | GO:0000811 | GINS complex(GO:0000811) |
0.7 | 7.6 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.7 | 2.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.7 | 13.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 2.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 4.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.7 | 7.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.7 | 2.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.7 | 3.3 | GO:0005638 | lamin filament(GO:0005638) |
0.6 | 4.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.6 | 5.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.6 | 14.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.6 | 2.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 2.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 3.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 9.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 6.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.6 | 3.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.6 | 7.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.6 | 2.4 | GO:0098536 | deuterosome(GO:0098536) |
0.6 | 1.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 2.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.6 | 18.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 25.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.6 | 1.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.6 | 2.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 9.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.6 | 2.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 0.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.6 | 3.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 1.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.6 | 3.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.5 | 2.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.5 | 2.2 | GO:0000805 | X chromosome(GO:0000805) |
0.5 | 1.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 1.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 2.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.5 | 1.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 4.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 2.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.5 | 20.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.5 | 7.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 1.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 1.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.5 | 1.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 47.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.5 | 2.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.5 | 2.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 2.4 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.5 | 1.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 4.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.5 | 1.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.5 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 2.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 0.9 | GO:0005687 | U4 snRNP(GO:0005687) |
0.5 | 3.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 5.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 3.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.5 | 3.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.5 | 2.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 2.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 2.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 1.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.4 | 2.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 1.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 9.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 3.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 3.9 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 3.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 2.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 4.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 2.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 2.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 2.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 5.3 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 3.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.4 | 1.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 2.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 1.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 3.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 1.5 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.4 | 6.2 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 3.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 2.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 4.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 3.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 3.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.4 | 0.4 | GO:0042827 | platelet dense granule(GO:0042827) |
0.4 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 2.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 0.4 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.4 | 1.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 1.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 2.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 0.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 4.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 19.4 | GO:0016605 | PML body(GO:0016605) |
0.3 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 2.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 1.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 1.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 5.1 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 1.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 1.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 6.1 | GO:0071010 | prespliceosome(GO:0071010) |
0.3 | 1.7 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.3 | 3.3 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 2.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 13.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 3.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 1.0 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 3.0 | GO:0097346 | Ino80 complex(GO:0031011) INO80-type complex(GO:0097346) |
0.3 | 6.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 1.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 24.8 | GO:0000776 | kinetochore(GO:0000776) |
0.3 | 1.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.3 | 1.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 5.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 0.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 1.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 1.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 3.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 2.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 10.5 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 4.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 3.3 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 0.6 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 1.5 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 0.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 12.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.6 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 4.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 0.6 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.3 | 1.7 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 2.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 1.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 3.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 2.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 3.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 4.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 1.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 3.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.3 | 1.6 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 6.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 1.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 15.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.3 | 3.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 1.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 9.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 6.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 12.6 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 0.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.3 | 1.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 6.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 0.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 0.8 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 2.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 8.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 10.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.3 | 0.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 1.0 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 2.0 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 5.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 2.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 2.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 10.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 3.6 | GO:0005844 | polysome(GO:0005844) |
0.2 | 2.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 8.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.9 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 2.3 | GO:0002102 | podosome(GO:0002102) |
0.2 | 4.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 1.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 1.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 0.2 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 3.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 1.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 4.5 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 26.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 5.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 10.6 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 1.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 3.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 3.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 0.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 1.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.8 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.8 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 1.3 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 64.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.6 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 6.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 4.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 2.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 2.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 12.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.6 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 0.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 3.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 2.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 2.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 16.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 5.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 10.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 2.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 12.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 2.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 3.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.2 | 0.7 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 18.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 8.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 1.3 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.5 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.2 | GO:0030894 | replisome(GO:0030894) |
0.2 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 1.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 2.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 18.3 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 46.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 2.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 2.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 2.2 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 2.1 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 3.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 1.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.1 | 111.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 2.4 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 129.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 1.5 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 0.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 2.1 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 4.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.7 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 1.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.1 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 7.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 4.2 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 9.7 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.9 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 3.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.1 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 4.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 2.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 12.6 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 63.8 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 2.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 9.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 2.5 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 2.5 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 4.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.0 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.6 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 8.1 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 2.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 38.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 3.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.0 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 1.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 7.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 17.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.3 | 6.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
3.1 | 9.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.7 | 10.9 | GO:0015265 | urea channel activity(GO:0015265) |
2.6 | 10.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.4 | 9.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.1 | 14.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.9 | 7.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.8 | 5.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.8 | 5.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.8 | 5.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.7 | 5.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.6 | 4.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.6 | 4.7 | GO:0019961 | interferon binding(GO:0019961) |
1.4 | 4.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.4 | 4.2 | GO:0050692 | DBD domain binding(GO:0050692) |
1.4 | 4.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.3 | 7.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.3 | 1.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.2 | 8.6 | GO:0018640 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.2 | 3.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.2 | 6.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.2 | 4.9 | GO:0043515 | kinetochore binding(GO:0043515) |
1.2 | 4.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.2 | 8.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.1 | 3.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.1 | 4.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.1 | 4.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.1 | 3.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.1 | 3.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.1 | 3.3 | GO:0048030 | disaccharide binding(GO:0048030) |
1.1 | 9.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.1 | 3.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.1 | 4.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.1 | 6.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.1 | 1.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.0 | 4.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.0 | 5.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 6.0 | GO:0043559 | insulin binding(GO:0043559) |
0.9 | 0.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.9 | 2.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.9 | 2.8 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.9 | 2.7 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.9 | 1.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.9 | 3.5 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 3.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.9 | 3.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.8 | 6.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.8 | 1.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 2.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.8 | 2.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.8 | 6.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 4.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.8 | 4.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 5.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.8 | 2.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.8 | 4.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 3.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.8 | 6.2 | GO:0008430 | selenium binding(GO:0008430) |
0.8 | 7.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.8 | 0.8 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.8 | 2.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.8 | 4.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.8 | 7.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.8 | 4.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.8 | 3.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 6.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.8 | 2.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.8 | 3.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.7 | 3.7 | GO:0070061 | fructose binding(GO:0070061) |
0.7 | 3.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 2.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.7 | 1.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.7 | 3.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.7 | 3.6 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 2.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.7 | 5.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.7 | 2.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.7 | 2.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.7 | 4.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.7 | 2.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.7 | 0.7 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.7 | 1.4 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.7 | 10.7 | GO:0005521 | lamin binding(GO:0005521) |
0.7 | 0.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.7 | 2.1 | GO:1990188 | euchromatin binding(GO:1990188) |
0.7 | 2.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.7 | 4.9 | GO:0005113 | patched binding(GO:0005113) |
0.7 | 5.6 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.7 | 2.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 2.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.7 | 2.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.7 | 2.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 5.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.7 | 2.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 3.4 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.7 | 7.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.7 | 2.0 | GO:0004064 | arylesterase activity(GO:0004064) |
0.7 | 2.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.7 | 2.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.7 | 10.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 6.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.7 | 0.7 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.7 | 4.6 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.7 | 4.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 2.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.6 | 1.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 2.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 1.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.6 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 3.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.6 | 1.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.6 | 2.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.6 | 2.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 4.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 11.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.6 | 6.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 3.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 2.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 2.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.6 | 11.4 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 3.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.6 | 1.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.6 | 2.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 5.3 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.6 | 2.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.6 | 4.7 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.6 | 2.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.6 | 0.6 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.6 | 5.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.6 | 1.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 1.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.6 | 2.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 2.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.6 | 3.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.6 | 1.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.6 | 2.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.6 | 1.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 1.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.6 | 2.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.6 | 0.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.6 | 1.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.6 | 3.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.6 | 3.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.5 | 3.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 18.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 4.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 1.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.5 | 8.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.5 | 2.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.5 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 1.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 2.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.5 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 2.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 17.0 | GO:0043531 | ADP binding(GO:0043531) |
0.5 | 1.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 1.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 4.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 3.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.5 | 2.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.5 | 2.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.5 | 1.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 2.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 1.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 3.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.5 | 1.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 2.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 1.5 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.5 | 2.0 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.5 | 5.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 14.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 2.0 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.5 | 1.5 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.5 | 1.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.5 | 12.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.5 | 1.5 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 1.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.5 | 1.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 3.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 1.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.5 | 2.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 1.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.5 | 1.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 4.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.5 | 1.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.5 | 2.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.5 | 1.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 7.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.5 | 0.9 | GO:0015928 | fucosidase activity(GO:0015928) |
0.5 | 2.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.5 | 1.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.5 | 1.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 5.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 1.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.5 | 1.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.5 | 2.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.4 | 3.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 1.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 4.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 2.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 2.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 2.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 1.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 0.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 0.4 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.4 | 2.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.4 | 13.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.4 | 1.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 2.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 6.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 3.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 1.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 8.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 6.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 4.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 1.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 2.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 1.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 1.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 1.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 6.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 1.7 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 1.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 1.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 0.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 1.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 1.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 2.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 1.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 0.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 8.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 2.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 2.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 4.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 12.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 2.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 1.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 4.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 5.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 1.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 1.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 1.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 17.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 1.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 1.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.4 | 0.8 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 1.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 2.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 1.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.4 | 2.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 5.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 2.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 1.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 4.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.4 | 1.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 8.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 0.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 2.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.4 | 0.4 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.4 | 0.4 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 2.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 1.9 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.4 | 1.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.4 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 0.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 1.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 1.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 4.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 2.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 1.5 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 5.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 16.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.4 | 4.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 6.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 2.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.4 | 14.0 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.4 | 4.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 1.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 20.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 4.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 1.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 1.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 2.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.3 | 1.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 1.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 1.0 | GO:0080084 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 1.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 4.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 2.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 3.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 8.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 3.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 9.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 0.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 2.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 1.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 1.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 2.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 5.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 1.6 | GO:0032452 | demethylase activity(GO:0032451) histone demethylase activity(GO:0032452) |
0.3 | 9.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 3.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 6.3 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 1.9 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.3 | 0.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 1.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 7.2 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.3 | GO:0035276 | ethanol binding(GO:0035276) |
0.3 | 1.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.3 | 1.9 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 4.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 8.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 5.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 0.3 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 3.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 1.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 2.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 0.9 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 4.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 5.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.3 | 1.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 4.7 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 1.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 0.9 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 1.4 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 0.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 6.9 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.3 | 0.9 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 4.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 4.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 1.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 1.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.3 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 5.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 6.0 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 1.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 0.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 1.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 1.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 1.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 3.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 3.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 1.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 0.8 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 1.1 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.3 | 1.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 0.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 4.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 1.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 1.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 0.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 1.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 1.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 0.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 1.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 2.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 1.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 9.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 0.3 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.3 | 1.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 0.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
0.3 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 2.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 1.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 1.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 1.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 12.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 1.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.7 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 6.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.2 | 2.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 1.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 10.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 1.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 2.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 3.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 1.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 2.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 4.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 2.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 1.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 1.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 3.9 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 8.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 1.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 1.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 4.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 1.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 11.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 2.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 16.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 8.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.9 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 1.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 18.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 1.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 1.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 1.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 2.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 2.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.4 | GO:0070990 | snRNP binding(GO:0070990) |
0.2 | 0.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 1.4 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 4.1 | GO:0032813 | tumor necrosis factor receptor binding(GO:0005164) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.2 | 1.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 1.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 1.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 1.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 2.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 4.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 1.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 9.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 1.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.6 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 2.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 1.7 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 0.2 | GO:0016749 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.2 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 5.2 | GO:0080031 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 1.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 0.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 2.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 1.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 0.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.2 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 1.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.4 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 2.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 4.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.5 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 1.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.7 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 9.3 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 1.6 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.2 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 6.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 1.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.9 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.2 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 0.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 1.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.2 | 1.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 5.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.2 | 1.0 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 1.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 2.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 1.3 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 1.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 9.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 2.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.5 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 4.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 2.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 4.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 3.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 3.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 0.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 12.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 8.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.2 | 5.5 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.2 | 0.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 10.9 | GO:0050662 | coenzyme binding(GO:0050662) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 24.6 | GO:0008766 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.1 | 0.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.9 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 1.4 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 1.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 5.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.7 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 23.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 3.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.4 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 11.5 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 2.3 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 12.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 2.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.9 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.6 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.5 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 7.3 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.5 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 1.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 3.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 1.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.1 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.1 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.5 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 1.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.5 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 52.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 1.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 2.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0016714 | phenylalanine 4-monooxygenase activity(GO:0004505) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 2.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 2.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.5 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 1.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.2 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.1 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 4.0 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 1.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.6 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 2.7 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.1 | 1.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.1 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.5 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.0 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.3 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 1.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.1 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.1 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.8 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 4.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 8.8 | GO:0019901 | protein kinase binding(GO:0019901) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.0 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.7 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 6.6 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 4.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 28.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.4 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 1.7 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.6 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 15.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.7 | 2.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.7 | 5.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 4.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 21.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 2.2 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 1.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 3.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 18.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 22.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 8.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 6.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 6.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 6.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.5 | 6.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 6.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 3.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 14.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.5 | 6.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 2.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 23.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 3.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 20.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 5.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 0.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 12.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 1.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 22.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 17.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 0.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 6.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 15.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 11.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 7.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 12.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 1.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 4.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 3.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 7.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 3.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 7.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 7.4 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 2.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 7.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 5.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 4.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 5.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 3.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 3.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 2.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 13.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 5.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 9.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 4.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 1.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 7.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 5.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 2.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 3.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 2.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 2.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 0.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 5.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 3.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 2.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 3.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 1.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 4.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 0.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 3.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 2.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 11.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 4.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 4.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 2.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 1.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 1.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 3.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 2.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.4 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 1.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 2.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.6 | 1.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.3 | 15.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.2 | 12.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.0 | 2.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.0 | 9.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.0 | 8.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.0 | 9.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.0 | 13.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.9 | 4.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.9 | 15.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.8 | 17.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.8 | 9.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.8 | 10.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.7 | 12.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.7 | 5.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 7.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 10.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.7 | 10.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.7 | 9.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 2.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.7 | 7.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.7 | 7.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 2.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.6 | 5.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 11.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.6 | 14.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.6 | 5.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 5.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.6 | 5.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.6 | 13.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 7.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.5 | 0.5 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.5 | 13.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 8.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.5 | 11.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 9.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 3.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 6.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 9.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 36.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.5 | 4.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.5 | 5.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 5.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 5.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 0.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.5 | 4.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 2.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 3.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.5 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 2.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.5 | 5.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.5 | 4.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 1.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 4.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.5 | 2.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 2.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.4 | 4.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 0.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.4 | 30.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 13.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 2.2 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.4 | 13.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 12.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 8.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 3.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 4.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 3.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 0.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 0.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 7.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 2.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 7.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.4 | 2.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 4.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 3.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 8.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 6.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 4.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 14.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 4.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 2.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 7.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 8.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 3.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 2.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 8.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 1.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 5.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 1.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 7.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 3.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.3 | 2.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 8.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 3.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 8.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 4.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 2.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 2.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 3.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 6.4 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 2.8 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 2.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.3 | 2.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 8.0 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 1.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 0.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 2.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 3.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 5.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.3 | 12.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 3.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 1.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 2.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 2.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 6.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 2.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 2.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 2.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 18.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 2.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 11.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 4.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 10.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 2.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 3.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 3.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 6.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 1.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 1.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 12.3 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.2 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 1.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 3.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 3.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 1.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 1.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 1.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 0.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 23.0 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 2.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 22.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 5.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 2.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 6.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 1.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 3.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 2.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 2.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 5.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 4.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 3.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 2.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 0.5 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.2 | 1.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 1.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 1.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.9 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 1.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.7 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 2.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 4.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 3.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 5.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 3.4 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 0.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 1.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 2.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 1.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.7 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.1 | 1.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.8 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 1.2 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 1.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 2.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.7 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |